Browsing Tag
Achin Gupta
5 posts
Why is Cipla’s InvaGen cutting 205 New York jobs while the US pipeline keeps expanding?
InvaGen Pharmaceuticals is preparing 205 permanent layoffs across two New York facilities effective November 27, adding a workforce dimension to Cipla's North American reset after regional revenue fell 21% in its latest reported quarter. The notices cite economic reasons but do not indicate a complete withdrawal from US manufacturing.
Cipla Limited (NSE: CIPLA) secures FDA approval for generic nintedanib capsules, entering a $3.8bn U.S. pulmonary fibrosis market
Cipla wins FDA approval for generic nintedanib capsules for IPF, targeting Boehringer Ingelheim's $3.76B Ofev market. Here's what the launch means for investors. Read more.
Cipla launches Cippoint point-of-care testing device in India
Indian pharma company Cipla Limited has launched a point-of-care testing device called Cippoint in India for infectious diseases,…
Cipla to acquire 21% stake in medical test kits provider Achira Labs
Cipla Limited has agreed to acquire a stake of 21.05% in Achira Labs, a provider of point of…
Glenmark Pharmaceutical launches Tiogiva in UK for COPD treatment
Glenmark Pharmaceutical has announced the UK launch of Tiogiva, a bioequivalent version of Tiotropium Bromide dry powder inhaler…